Found 18 matching trials
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer PHASE1 This is a multi-site, global, open-label study that includes a phase 1b eva...
Show More Location
Providence Medical Foundation
Learn More & Join Trial
A Study to Evaluate the Effects of RAD1901 in the Treatment of Vasomotor Symptoms in Postmenopausal Women PHASE2 The purpose of this study is to determine whether RAD1901 is effective in d...
Show More Location
Radius Health, Inc.
Learn More & Join Trial
A PK Study Testing Single Oral Dose of Elacestrant in Subjects With Normal or Severely Impaired Hepatic Function PHASE1 This is a Phase 1, multi-center, open-label, non-randomized, parallel group...
Show More Location
Inland Empire Clinical Trials, LLC
Learn More & Join Trial
Study to Evaluate the Safety and Efficacy of RAD1901 in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms PHASE2 The primary objective of this study was to determine the clinical safety of...
Show More Location
Women's Health Care Specialists P.C. - Beyer Research
Learn More & Join Trial
A Phase I, Multicenter, Open-Label, Multi-Part, Dose-escalation Study of RAD1901 in Postmenopausal Women With Advanced Estrogen Receptor Positive and HER2-Negative Breast Cancer PHASE1 The purpose of this study is to evaluate the safety, tolerability and preli...
Show More Location
Radius Pharmaceuticals, Inc.
Learn More & Join Trial
Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer PHASE1 This is a multicenter, Phase 1b/2 trial in participants with estrogen recep...
Show More Status
Active Not Recruiting
Location
Dothan Hematology and Oncology
Learn More & Join Trial
A Rollover Protocol of Elacestrant, in Combination With Onapristone, for Patients With ER+, PR+, HER2- Advanced or Metastatic Breast Cancer PHASE1 This is a rollover study for patients enrolled in the discontinued ELONA cl...
Show More Location
Sarah Cannon Research Institute
Learn More & Join Trial
Study of Elacestrant in Combination With Onapristone in Patients With Advanced or Metastatic Breast Cancer PHASE1 This is a multicenter, Phase 1b-2 study of elacestrant in combination with ...
Show More Location
Cancer Treatment Centers of America - Western Regional Medical Center
Learn More & Join Trial
Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i. PHASE3 This trial will study a type of advanced breast cancer (ABC) defined as end...
Show More Location
Medizinische Universität Innsbruck
Learn More & Join Trial
ELACESTRANT in Women and Men With CDK4/6 Inhibitor-Naive Estrogen Receptor Positive, HER-2 Negative Metastatic Breast Cancer Study PHASE2 The purpose of this study is to evaluate the efficacy and safety of elacest...
Show More Status
Active Not Recruiting
Location
Highlands Oncology Group, PA
Learn More & Join Trial